Pharming inks China deal; Alnylam reports PhII data;

 @JohnCFierce: The FDA's suvorexant decision was expected. I don't see how weak suvo competes with the generics. It'll be an alternative for non-response. | Follow @JohnCFierce

 @RyanMFierce: Onyx is following the M&A resistance strategy, which Termeer and more recently Martin have used. More | Follow @RyanMFierce

> Pharming has completed a tech transfer deal with a subsidiary of China's Sinopharm. They'll work jointly on new drug development projects. Story

> Cambridge, MA-based Alnylam ($ALNY) says it reaped positive clinical results from its Phase II trial of ALN-TTR02, an RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis. Release

> The CEO of Melbourne-based Phosphagenics has reportedly been suspended pending an investigation into "irregular transactions." Story

> Bayer and partner Onyx ($ONXX) have submitted a supplemental NDA to the FDA seeking an OK to use Nexavar as a treatment for thyroid cancer. Release

Medical Device News

 @FierceMedDev: Veracyte nails $28M Series C. Story | Follow @FierceMedDev

 @MarkHFierce: There's still time to submit your nomination for this year's FMD Fierce 15. More | Follow @MarkHFierce

 @DamianFierce: Thoratec is spending up to $56.5M for Terumo's in-development heart device. News | Follow @DamianFierce

> Malaysia's new device regs poised to heighten the competition. Article

> A drug-free Covidien is now all about devices. Story

> Zyomyx pulls in $12M to advance low-cost HIV Dx to finish line. More

Pharma News

 @FiercePharma: Fresenius Kabi yanks four lots of benztropine mesylate on risk of glass particles, stops distribution to investigate. News | Follow @FiercePharma

 @EricPFierce: ICYMI: FDA approves first non-hormonal treatment for hot flashes. Release | Follow @EricPFierce

> Merck KGaA sees U.S. as "emerging market" for sales growth. More

> Pfizer, Bristol-Myers tout new VTE data on Eliquis, aiming for new use. News

CRO News

> MMS teams up with Datatrak for eClinical heft. Story

> Want to work with Roche? Prepare for high standards. More

> AstraZeneca taps Sarah Cannon for cancer R&D. Article

Biotech IT News

> Ex-Googlers bring Big Data analytics to oncology. News

> Deloitte turns EHR reservoir into health outcomes tool. Article

> J&J teams up with Mount Sinai on bioinformatics project. Story

> Data secrecy and outdated tech exacerbating drug shortages. More

And Finally… A new study concludes that people who regularly smoke marijuana produce less dopamine in the brain, which could be connected to lowered motivation. Release

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.